In this article ‘A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice’ by, Masami Sairyo et al., which appeared in J Atheroscler Thromb, 2018; 25: 142–152 are incorrect.
. 2018 Oct 1;25(10):1088. doi: 10.5551/jat.ER39693
Erratum:A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice
Masami Sairyo
, Takuya Kobayashi
, Daisaku Masuda
, Koutaro Kanno
, Yinghong Zhu
, Takeshi Okada
, Masahiro Koseki
, Tohru Ohama
, Makoto Nishida
, Yasushi Sakata
, Shizuya Yamashita
Masami Sairyo
Find articles by Masami Sairyo
Takuya Kobayashi
Find articles by Takuya Kobayashi
Daisaku Masuda
Find articles by Daisaku Masuda
Koutaro Kanno
Find articles by Koutaro Kanno
Yinghong Zhu
Find articles by Yinghong Zhu
Takeshi Okada
Find articles by Takeshi Okada
Masahiro Koseki
Find articles by Masahiro Koseki
Tohru Ohama
Find articles by Tohru Ohama
Makoto Nishida
Find articles by Makoto Nishida
Yasushi Sakata
Find articles by Yasushi Sakata
Shizuya Yamashita
Find articles by Shizuya Yamashita
Japan Atherosclerosis Society
This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/
PMCID: PMC6193185 PMID: 30197400
This corrects the article "A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice" on page 142.